Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

類似資料

• First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
  著者:: Feliu, J, 等
  出版事項: (2014)
• Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
  著者:: Feliu, J, 等
  出版事項: (2010)
• Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study
  著者:: Nogué, Miguel, 等
  出版事項: (2011)
• A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
  著者:: Salazar, Ramon, 等
  出版事項: (2015)
• Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
  著者:: Garcia-Alfonso, Pilar, 等
  出版事項: (2015)